Trade JUNS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Jupiter Neurosciences, Inc. (JUNS) is trading at US$4.18, down 14.52% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$4.77M. Over the past 52 weeks, JUNS has traded between US$4.10 and US$137.96. On Syfe you can trade JUNS with $0 commission and add it to your watchlist.
| Previous close | US$4.89 |
|---|---|
| Market cap | US$4.77M |
| 52-week range | US$4.10 – US$137.96 |
| Volume | 151.65K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.
Year: 2024
Jupiter Neurosciences Obtains Exclusive US Rights to Potential Psychedelic Therapy for Up to $100 Million
Jul 21, 12:00 PM · MT Newswires
Jupiter Neurosciences, Inc. (JUNS) stock is trading at US$4.18, -14.52% from the previous close of US$4.89.
The market cap for Jupiter Neurosciences, Inc. (JUNS) stock is approximately US$4.77M.
The 52-week high for Jupiter Neurosciences, Inc. (JUNS) stock is US$137.96.
The 52-week low for Jupiter Neurosciences, Inc. (JUNS) stock is US$4.10.
Jupiter Neurosciences, Inc. (JUNS) does not currently pay a dividend.
Stay on top of JUNS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
